RYTM: Rhythm Pharmaceuticals, Inc. Stock

by  •  • Comments Off on RYTM: Rhythm Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 3,257.22
Enterprise Value ($M) 3,419.18
Book Value ($M) 164.55
Book Value / Share 2.64
Price / Book 19.79
NCAV ($M) 146.48
NCAV / Share 2.35
Price / NCAV 22.24

Profitability (mra)
Return on Invested Capital (ROIC) -0.94
Return on Assets (ROA) -0.78
Return on Equity (ROE) -1.54

Liquidity (mrq)
Quick Ratio 3.08
Current Ratio 3.24

Balance Sheet (mrq) ($M)
Current Assets 374.20
Assets 392.27
Liabilities 227.72
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 130.13
Operating Income -265.50
Net Income -260.60
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G/A Primecap Management Co/ca/ 10.69 -8.95
02-10 13G/A Goldman Sachs Group Inc 3.00 -53.25
11-14 13G Perceptive Advisors Llc 8.60 5.67
11-14 13G/A Ra Capital Management, L.p. 9.95 14.15
04-30 13D/A New Enterprise Associates 13 Lp
2024-02-14 13G/A Baker Bros. Advisors Lp 10.80 0.69
2024-02-13 13G Vanguard Group Inc 5.46

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-28 10-K ‘ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-14 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-28 58,550 511,379 11.45
2025-02-27 78,539 406,054 19.34
2025-02-26 108,820 625,095 17.41

(click for more detail)

Similar Companies
RLAY – Relay Therapeutics, Inc. RNA – Avidity Biosciences, Inc.
RNAC – Cartesian Therapeutics, Inc. SAGE – Sage Therapeutics, Inc.
SCYX – SCYNEXIS, Inc.


Financial data and stock pages provided by
Fintel.io